SCHEMBL7106230

SCHEMBL7106230

NS(=O)(=O)Oc1ccc(-c2nc3ccccc3s2)c(I)c1.[NaH]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.47
KDM4E B2RXH2 6/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44
CDK5 Q00535 1/20 0.44
CDK5R1 Q15078 1/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
GAA P10253 3/20 0.44
APP P05067 3/20 0.44
TDP1 Q9NUW8 3/20 0.44
L3MBTL1 Q9Y468 3/20 0.44
POLB P06746 1/20 0.44
THRB P10828 1/20 0.44
ALOX15 P16050 1/20 0.44
CASP1 P29466 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7108926 0.86 MAPT (0.49) MAPTKDM4ENPC1RAB9ANPSR1
SCHEMBL7112524 0.80 RAB9A (0.61) MAPTKDM4ENPC1RAB9ANPSR1
Ammonia Solution, Strong SCHEMBL7109726 0.77 RAB9A (0.61) MAPTKDM4ENPC1RAB9ANPSR1
SCHEMBL7109795 0.75 TP53 (0.49) MAPTKDM4ENPC1RAB9ANPSR1
SCHEMBL7106226 0.74 TP53 (0.48) MAPTKDM4ENPC1RAB9ANPSR1
SCHEMBL22052874 0.71 KDM4E (0.64) MAPTKDM4ENPC1RAB9ANPSR1
SCHEMBL8393318 0.71 KDM4E (0.52) MAPTKDM4ENPC1RAB9ANPSR1
SCHEMBL27205436 0.69 CA12 (0.57) MAPTNPC1RAB9ACCNE1CDK2
SCHEMBL31482694 0.68 MAPT (0.72) MAPTKDM4ENPC1RAB9ANPSR1
SCHEMBL5981201 0.68 MAPT (0.71) MAPTKDM4ENPC1RAB9ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812319-B9 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2003-10-08 EP disclosed
EP-0812319-B1 2-ARYLBENZAZOLE COMPOUNDS CANCER RES VENTURES LTD (GB) 2002-07-10 EP disclosed
EP-0812319-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1997-12-17 EP disclosed
WO-1996026932-A1 2-ARYLBENZAZOLE COMPOUNDS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-09-06 WO disclosed